KTRA - Why Kintara Therapeutics Shares Are Gaining Today | Benzinga
Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares are trading higher in the premarket session on Wednesday with heavy volume.
The company entered into a definitive merger agreement with TuHURA Biosciences.
The combined company will focus on advancing TuHURA’s personalized cancer vaccines and bi-functional ADCS. These two technologies seek to overcome the major obstacles that limit the effectiveness of current immunotherapies in treating cancer.
The combined company is expected to operate under the name TuHURA Biosciences, Inc. and trade on the ...